Tissue-resident memory T cells play a key role in the efficacy of cancer vaccines
Resident memory CD8+T cells (TRM) usually defined by the CD103 marker represent a new subset of long-lived memory T cells that remain in the tissues. We directly demonstrate their specific role in cancer vaccine-induced tumor regression. In human, they also seem to play a major role in tumor immunos...
Main Authors: | C. Granier, C. Blanc, S. Karaki, T. Tran, H. Roussel, E. Tartour |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-11-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1358841 |
Similar Items
-
Resident memory T cells, critical components in tumor immunology
by: Fathia Mami-Chouaib, et al.
Published: (2018-09-01) -
Targeting Resident Memory T Cells for Cancer Immunotherapy
by: Charlotte Blanc, et al.
Published: (2018-07-01) -
Mécanismes de l’immunogénicité des cellules cancéreuses hyperploïdes
by: Bloy, Norma
Published: (2017) -
Sarcoma Immunotherapy
by: R. Lor Randall, et al.
Published: (2011-11-01) -
Tissue-resident lymphocytes: sentinel of the transformed tissue
by: Saïda Dadi, et al.
Published: (2017-05-01)